Stream
Stories
-
Results posted for phase 3 orforglipron study in type 2 diabetes
Results for this study were first posted on ClinicalTrials.gov on October 1, 2026. The study enrolled 546 participants and completed primary data collection on September 15, 2025.
-
Results posted for estradiol vaginal insert study
Results for this study were first posted on ClinicalTrials.gov on September 30, 2026. The study enrolled 1050 participants and completed primary data collection on March 15, 2024.
-
Results posted for TAK-881 PK, safety study in primary immunodeficiency diseases
Results for this study were first posted on ClinicalTrials.gov on September 30, 2026. The study enrolled 65 participants and completed primary data collection on January 20, 2026.
-
Results posted for LicartTM topical system study
Results for this study were first posted on ClinicalTrials.gov on September 30, 2026. The study enrolled 151 participants, started on October 31, 2021, and completed primary data collection on June 30, 2024.
-
FDA classifies flushing and storage solution for vascular autografts at room temperature as class II
The FDA announced that it is classifying the flushing and storage solution for vascular autografts at room temperature into class II (special controls). The order identifies the special controls that apply to the device type and will be part of the codified language for classification of the flushing and storage solution for vascular autografts at room temperature.